Waters Corporation and Princeton Sign Multi-Year Research Collaboration

Written by
Tracy Meyer, Corporate Engagement and Foundation Relations
June 26, 2023

Princeton and the Waters Corporation recently signed a multi-year research agreement  that "will enable scientists, faculty, and students to work together to bring their diverse skills and backgrounds to solve complex challenges in biochemistry and materials science." 

The collaboration will center on the University's Princeton Bioengineering Initiative (PBI).  The first joint project will aim to advance drug discovery and development research using bioseparation techniques. Cliff Brangwynne, June K Wu '92 Professor in Engineering and an HHMI investigator, is the PBI director. Jose L. Avalos, an associate professor of Chemical and Biological Engineering and the Andlinger Center for Energy and the Environment, is the principal investigator. Additional joint research areas may include higher-purity pharmaceuticals, advanced analytical workflows, materials science, and advancements in drug development.

Waters Corporation executives and Princeton faculty and staff are behind a table with documents at Prospect House.
In addition to meeting with Vice Dean Arnold, Waters executives met with Professor Cliff Brangwynne, director of the Princeton Bioengineering Initiative. Back: Dean Edelman, CEFR; Brangwynne; Daniel Rush, Waters; Coleen Burrus, CEFR director. Front: Batra; Arnold. Photo: Phil McAuliffe.

"As a leading global institution of research and teaching, Princeton welcomes collaborations with industry to enrich education and accelerate research and innovation for societal benefit," said Craig Arnold, Princeton University Vice Dean for Innovation and the Susan Dod Brown Professor of Mechanical and Aerospace Engineering. "We involved many Princeton faculty in our conversations with Waters as we considered this new relationship, and we were delighted to identify numerous research topics of mutual interest that build on Princeton's strengths in bioengineering and materials science and the distinctive capabilities of the Princeton Bioengineering Initiative. We believe our research collaborations will advance science and offer our faculty and students new opportunities."

Bioengineering is one of several interdisciplinary areas recently identified by the Princeton Board of Trustees for "game-changing investments." Learn more about bioengineering at Princeton.

Waters Corporation is a global leader in analytical instruments and software and has pioneered chromatography, mass spectrometry, and thermal analysis innovations serving the life, materials, and food sciences for over 60 years. The company has more than 8,200 employees worldwide. Read the Waters Corporation announcement.